3i, LP 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-13 9:08 pm Sale |
2025-03-31 | 13G | BriaCell Therapeutics Corp. BCTX |
3i, LP | 190,006 4.900% |
-178,994 (-48.51%) |
Filing |
| 2025-02-10 9:02 pm Purchase |
2025-02-05 | 13G | BriaCell Therapeutics Corp. BCTX |
3i, LP | 369,000 9.900% |
369,000 (New Position) |
Filing |